|
|
||||||||
Case Report |
1 Cantonal Institute of Microbiology, Via Mirasole 22A, 6500 Bellinzona, Switzerland
2 Intensive Care Unit, Regional Hospital, 6900 Lugano, Switzerland
Correspondence
Antonella Demarta
antonella.demarta{at}ti.ch
Received 1 February 2007
Accepted 2 July 2007
Abbreviations: TTSS, type III secretion system.
The GenBank/EMBL/DDBJ accession number for the gyrB sequence of the Aeromonas veronii strain is AM490258.
| Introduction |
|---|
|
|
|---|
Several agents of pneumonia have been isolated from near-drowning patients, Aeromonas strains being the most regularly reported Gram-negative bacilli (Ender & Dolan, 1997; Mukhopadhyay et al., 2003). Aeromonas hydrophila was the most frequent species mentioned in a recent review of approximately 20 cases of Aeromonas pneumonia (Kao et al., 2003).
Eighteen Aeromonas species have been described so far (Saavedra et al., 2006), but only five (A. hydrophila, Aeromonas caviae, Aeromonas veronii, Aeromonas jandaei and Aeromonas schubertii) have been identified as human pathogens (Janda & Abbot, 1998). A. veronii comprises two biovars, veronii and sobria, that are two heterogeneous phenotypes of the same species. A. veronii biovar sobria is one of three species (together with A. hydrophila and A. caviae) recovered predominantly from clinical materials, and involved in extraintestinal and systemic bacterial infections (Janda & Abbot, 1998). A. veronii biovar veronii, on the other hand, is rarely reported as a human pathogen (Janda & Abbot, 1998), and little information is available on its occurrence in clinical samples and its ability to cause infections.
Here we report a case of tracheobronchitis caused by an Aeromonas isolate that was found to possess determinants of virulence. The strain was identified as A. veronii biovar sobria by biochemical and molecular analyses.
| Case report |
|---|
|
|
|---|
Bronchoscopy showed an acute tracheobronchitis of moderate severity with the presence of a non-occluding, yellow-reddish bronchial secretion in which an Aeromonas sp. was the predominant micro-organism. Antibiotic therapy with cefepime was immediately started. Microbiological analysis showed that the isolated strain was resistant to ampicillin and amoxicillin/clavulanic acid, but sensitive to cephalosporins, gentamicin, tobramycin, tetracycline, ciprofloxacin and trimethoprim/sulfamethoxazole. Thus, the antibiotic therapy was not changed. Chest X-ray revealed bilateral roundish alveolar thickenings and a right basal paracardiac opacity congruent with an infiltration following inhalation. Clinical evaluation showed an improvement in the respiratory indexes and the patient was extubated. Neurological signs indicated a severe post-anoxic encephalopathy leading to the discontinuation of the therapies on day nine. A few hours after discontinuation of therapy the patient died.
The bronchial secretion was plated on classical microbiological media and yielded an almost pure culture of Gram-negative rods. These bacilli were oxidase-positive, resistant to the vibriostatic agent O/129 and strongly haemolytic on blood agar. The API-20 NE (bioMérieux) profile suggested the genus Aeromonas and further molecular identification of the strain was carried out using gyrB gene sequence analysis (Demarta et al., 2004). Sequence alignment and comparison with other gyrB sequences of Aeromonas available in the GenBank database was performed using MEGA 3.1 software (Kumar et al., 2004), and the strain was identified as A. veronii (GenBank accession no. AM490258). The positive reactions for the Voges–Proskauer and aesculin tests indicated that the strains belonged to the biovar sobria. The presence of a type III secretion system (TTSS), used by many Gram-negative bacteria to deliver effector proteins into host cells (Hueck, 1998), was confirmed by hybridization with a probe consisting of ascV, one of the genes encoding a TTSS (Burr et al., 2002).
| Discussion |
|---|
|
|
|---|
Aeromonas spp., however, are known to be among the most important aetiological agents of pneumonia following near-drowning events, with a reported mortality of almost 60 % (Ender & Dolan, 1997). As a result, Aeromonas must be always suspected as the first, potential cause of a pneumonia when the anamnesis reports contact with water. In our case, the near-drowning accident occurred in the mouth of a river where extensive investigations of the microbiological water quality carried out over a 10 year period had recorded Aeromonas concentrations between 250 and 500 c.f.u. ml–1 water (Istituto Cantonale Batteriosierologico, 1995).
The identification of most Aeromonas species by conventional biochemical tests is often inaccurate. In the case of the two biovars of A. veronii, results of biochemical tests do not always correlate well with genetic identification methods. For example, three A. veronii biovar sobria isolates identified by biochemical methods were assigned to Aeromonas allosaccharophila by gyrB sequence analysis (Saavedra et al., 2006). Graf (1999) demonstrated that the 16S rRNA sequences in the species A. veronii biovar sobria are variable. Therefore we decided to perform gyrB sequence analysis to confirm species identification. The results of the sequence analysis and biochemical tests allowed the identification of the strain as A. veronii biovar sobria.
The role of our A. veronii biovar sobria strain as the causative agent of tracheobronchitis was supported by its massive growth in the bronchial secretion, the presence of a TTSS and the strong haemolytic activity on blood agar.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |